deferoxamine has been researched along with aphidicolin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gelfand, EW; Lucas, JJ; Terada, N | 1 |
| Kiyokawa, H; Marks, PA; Richon, VM; Rifkind, RA; Venta-Perez, G | 1 |
| Brodie, C; Gelfand, E; Lucas, J; Schleicher, R; Seligman, P; Siriwardana, G; Szepesi, A; Terada, N | 1 |
| Farinelli, SE; Greene, LA | 1 |
| Berg, PE; Eskenazi, AE; Fan, L; Frantz, CN; Frick, KK; Ikegaki, N; Iyer, J; Kennett, RH; Wada, RK; Zhu, S | 1 |
| Furuyama, F; Hida, H; Isobe, Y; Jung, CG; Kim, TS; Masuda, T; Misumi, S; Nishino, H; Urakawa, S | 1 |
6 other study(ies) available for deferoxamine and aphidicolin
| Article | Year |
|---|---|
Differential regulation of the tumor suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells.
Topics: Aphidicolin; Blotting, Northern; Cell Cycle; Cyclosporins; Deferoxamine; Diterpenes; Gene Expression; Genes, Tumor Suppressor; Humans; In Vitro Techniques; Interleukin-2; Lymphocyte Activation; Phosphorylation; Proto-Oncogene Proteins c-myc; Receptors, Interleukin-2; Retinoblastoma Protein; RNA, Messenger; T-Lymphocytes; Time Factors; Tumor Suppressor Protein p53 | 1991 |
Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1.
Topics: Acetamides; Animals; Aphidicolin; Cell Differentiation; Cyclins; Deferoxamine; G1 Phase; Leukemia, Erythroblastic, Acute; Mice; Retinoblastoma Protein; Time Factors; Tumor Cells, Cultured | 1993 |
Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.
Topics: Aphidicolin; Cell Count; Cell Division; Deferoxamine; Drug Screening Assays, Antitumor; Ferritins; G1 Phase; Glioma; Humans; Iron; Neuroblastoma; Receptors, Transferrin; S Phase; Transferrin; Tumor Cells, Cultured | 1993 |
Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and postmitotic sympathetic neurons after removal of trophic support.
Topics: Animals; Aphidicolin; Apoptosis; Cell Cycle; Cell Division; Ciclopirox; Cyclic AMP; Deferoxamine; G1 Phase; Mimosine; Mitosis; Nerve Growth Factors; Neurons; Nocodazole; PC12 Cells; Pyridones; Rats; Superior Cervical Ganglion; Teniposide; Thionucleotides | 1996 |
Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
Topics: Aphidicolin; Apoptosis; Deferoxamine; Gene Expression; Gene Expression Regulation, Neoplastic; Genes, myc; Genes, Reporter; Humans; Hydroxyurea; Inhibitory Concentration 50; Iron; Iron Chelating Agents; Neuroblastoma; Promoter Regions, Genetic; Proto-Oncogene Proteins c-myc; Proto-Oncogenes; RNA, Messenger; Substrate Specificity; Transcription, Genetic; Tumor Cells, Cultured | 2001 |
Enhanced neurogenesis from neural progenitor cells with G1/S-phase cell cycle arrest is mediated by transforming growth factor beta1.
Topics: Animals; Aphidicolin; Cell Differentiation; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinase Inhibitor p27; Deferoxamine; Dopamine; Enzyme Inhibitors; Female; G1 Phase; Neurons; Phosphoprotein Phosphatases; Pregnancy; Rats; Rats, Wistar; Receptors, Transforming Growth Factor beta; S Phase; Siderophores; Signal Transduction; Smad3 Protein; Stem Cells; Transforming Growth Factor beta1; Tubulin | 2008 |